hair loss after stopping glp 1 reported during GLP-1 therapy is most commonly explained by telogen effluvium, a delayed response to rapid weight loss and undernutrition. ‌ Two key contributors I assess clinically: 👉🏻Low protein intake For those who had SEVERE

Nevertheless, other randomized clinical trials failed to demonstrate any beneficial effect of selenium supplementation in GD (81, 82) or in HT [79, 80]

However, the continuation of an existing treatment plan without GLP-1RA did not have such an effect

It doesn't automatically extend to compounded semaglutide or to patients without established cardiovascular disease

Desgagn M, et al., Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid-Free Analgesics

Significant positive correlations were observed between eryptosis level and all analyzed peritoneal biomarkers of peritonitis, highlighting a potential link between systemic effect (eryptosis) and local inflammation (peritoneum in PD-related peritonitis patients), and definitely confirmed that eryptosis is mostly influenced by blood composition [271]